Objective The COVID-19 pandemic has transformed care delivery for patients with opioid
use disorder (OUD); however, little is known about the experiences of front-line clinicians in …

Background This study investigated the efficacy and safety of providing medication for opioid
use disorder (MOUD) and individualized telehealth in Kentucky, a state severely impacted …

The coronavirus disease pandemic of 2019 (COVID-19) has created significant economic
and societal burden, with mortality currently exceeding 615,000 and millions of others …

Objective To understand clinician use of and opinions about telemedicine for opioid use
disorder (tele-OUD) during the COVID-19 pandemic. Methods An electronic national survey …

Introduction Opioid use disorder (OUD) is a debilitating illness that remains a serious public
health issue in the United States. Use of telemedicine to deliver m edications for the …

Background COVID-19 has exacerbated income inequality, structural racism, and social
isolation—issues that drive addiction and have previously manifested in the epidemic of …

Background To determine how clinicians with a DATA waiver to prescribe buprenorphine for
opioid use disorder (OUD) adapted during the COVID-19 pandemic to emergency …

Background: The drug-related overdose crisis worsened during the COVID-19 pandemic.
Recent drug policy changes to increase access to medications for opioid use disorder …

Low barrier addiction clinics increase access to medications to treat substance use
disorders, while emphasizing harm reduction. The Harm Reduction and BRidges to Care …

Federal regulatory changes during the COVID-19 pandemic allow buprenorphine to be
prescribed without an initial in-person evaluation. Prior to COVID-19, numerous barriers …